Clinical validation of a multi-protein, serum-based assay for disease activity assessments in multiple sclerosis

Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved.

Détails bibliographiques
Publié dans:Clinical immunology (Orlando, Fla.). - 1999. - 253(2023) vom: 25. Aug., Seite 109688
Auteur principal: Chitnis, Tanuja (Auteur)
Autres auteurs: Foley, John, Ionete, Carolina, El Ayoubi, Nabil K, Saxena, Shrishti, Gaitan-Walsh, Patricia, Lokhande, Hrishikesh, Paul, Anu, Saleh, Fermisk, Weiner, Howard, Qureshi, Ferhan, Becich, Michael J, da Costa, Fatima Rubio, Gehman, Victor M, Zhang, Fujun, Keshavan, Anisha, Jalaleddini, Kian, Ghoreyshi, Ati, Khoury, Samia J
Format: Article en ligne
Langue:English
Publié: 2023
Accès à la collection:Clinical immunology (Orlando, Fla.)
Sujets:Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S. Clinical validation Gadolinium-positive lesion MS disease activity Multiple sclerosis Blood Proteins Gadolinium AU0V1LM3JT